LFCR
Price
$7.23
Change
+$0.16 (+2.26%)
Updated
Dec 20, 04:59 PM (EDT)
11 days until earnings call
TLRY
Price
$1.26
Change
+$0.10 (+8.62%)
Updated
Dec 20 closing price
17 days until earnings call
Ad is loading...

LFCR vs TLRY

Header iconLFCR vs TLRY Comparison
Open Charts LFCR vs TLRYBanner chart's image
Lifecore Biomedical
Price$7.23
Change+$0.16 (+2.26%)
Volume$9.88K
CapitalizationN/A
Tilray Brands
Price$1.26
Change+$0.10 (+8.62%)
Volume$38.44M
CapitalizationN/A
LFCR vs TLRY Comparison Chart
Loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. TLRY commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and TLRY is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (LFCR: $7.24 vs. TLRY: $1.26)
Brand notoriety: LFCR: Not notable vs. TLRY: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LFCR: 385% vs. TLRY: 135%
Market capitalization -- LFCR: $176.87M vs. TLRY: $1.87B
LFCR [@Pharmaceuticals: Other] is valued at $176.87M. TLRY’s [@Pharmaceuticals: Other] market capitalization is $1.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileTLRY’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, LFCR is a better buy in the long-term than TLRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 6 TA indicator(s) are bullish while TLRY’s TA Score has 5 bullish TA indicator(s).

  • LFCR’s TA Score: 6 bullish, 3 bearish.
  • TLRY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than TLRY.

Price Growth

LFCR (@Pharmaceuticals: Other) experienced а -4.86% price change this week, while TLRY (@Pharmaceuticals: Other) price change was +5.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.34%. For the same industry, the average monthly price growth was -0.19%, and the average quarterly price growth was -10.14%.

Reported Earning Dates

LFCR is expected to report earnings on Apr 02, 2025.

TLRY is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.34% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.87B) has a higher market cap than LFCR($177M). LFCR YTD gains are higher at: 16.963 vs. TLRY (-45.217). LFCR has higher annual earnings (EBITDA): -22.64M vs. TLRY (-1.23B). TLRY has more cash in the bank: 260M vs. LFCR (4.22M). LFCR has less debt than TLRY: LFCR (157M) vs TLRY (529M). TLRY has higher revenues than LFCR: TLRY (700M) vs LFCR (188M).
LFCRTLRYLFCR / TLRY
Capitalization177M1.87B9%
EBITDA-22.64M-1.23B2%
Gain YTD16.963-45.217-38%
P/E RatioN/A8.52-
Revenue188M700M27%
Total Cash4.22M260M2%
Total Debt157M529M30%
FUNDAMENTALS RATINGS
LFCR vs TLRY: Fundamental Ratings
LFCR
TLRY
OUTLOOK RATING
1..100
9350
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9891
PRICE GROWTH RATING
1..100
4082
P/E GROWTH RATING
1..100
594
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (57) in the Biotechnology industry is somewhat better than the same rating for LFCR (90) in the Industrial Specialties industry. This means that TLRY’s stock grew somewhat faster than LFCR’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that TLRY’s stock grew similarly to LFCR’s over the last 12 months.

TLRY's SMR Rating (91) in the Biotechnology industry is in the same range as LFCR (98) in the Industrial Specialties industry. This means that TLRY’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's Price Growth Rating (40) in the Industrial Specialties industry is somewhat better than the same rating for TLRY (82) in the Biotechnology industry. This means that LFCR’s stock grew somewhat faster than TLRY’s over the last 12 months.

LFCR's P/E Growth Rating (5) in the Industrial Specialties industry is significantly better than the same rating for TLRY (94) in the Biotechnology industry. This means that LFCR’s stock grew significantly faster than TLRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRTLRY
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KLGBX41.430.40
+0.97%
NYLI WMC Growth Class B
PEDMX12.910.12
+0.92%
Principal Edge MidCap R6
GCEYX16.910.08
+0.48%
AB Global Core Equity Advisor
HNCSX17.65-0.02
-0.11%
Hartford International Growth R4
TRIEX22.46-0.04
-0.18%
Nuveen International Eq Idx Retire

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+2.40%
SHPH - LFCR
31%
Poorly correlated
-5.87%
CRON - LFCR
29%
Poorly correlated
+4.28%
CGC - LFCR
28%
Poorly correlated
+4.43%
TLRY - LFCR
27%
Poorly correlated
+8.62%
OGI - LFCR
26%
Poorly correlated
+6.85%
More